CX Institutional’s LeMaitre Vascular LMAT Stock Holding History

CX Institutional’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-15	Closed	-$1K	–	1618
2025 Q4	$1K	Buy	+15	New	+$1.29K	﹤0.01%	1470

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

CX Institutional's LMAT Position: Q1 2026 in Review

CX Institutional sold out of LeMaitre Vascular (LMAT) in Q1 2026, closing a stake of 15 shares — an estimated $1K sold.

CX Institutional first reported a position in LMAT in Q4 2025 and held it in 1 quarter. The position peaked at $1K in Q4 2025. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

CX Institutional reported no remaining LeMaitre Vascular position as of Q1 2026 after selling out during the quarter.
CX Institutional sold 15 LeMaitre Vascular shares in Q1 2026, an estimated $1K.
CX Institutional first reported a position in LeMaitre Vascular in Q4 2025 and held it in 1 quarter.
CX Institutional's LeMaitre Vascular position peaked at $1K in Q4 2025.
339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on CX Institutional's 13F filing for Q1 2026, filed 6 Apr 2026.